Article
Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.
Protein engineering, design & selection : PEDS - 1 Nov 2010
Goyanka Ritu, Das Sharmistha, Samuels Herbert H, Cardozo Timothy
Abstract excerpt
Nuclear receptors (NRs) comprise the second largest protein family targeted by currently available drugs, acting via specific ligand interactions within the ligand binding domain (LBD). Recently, farnesyl pyrophosphate (FPP) was shown to be a unique promiscuous NR ligand, activating a subset of NR family members and inhibiting wound healing in skin. The current study aimed at visualizing the unique basis of FPP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
